27 results
8-K
EX-3.2
VERV
Verve Therapeutics Inc
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
that are commonly incident to the office of the chief executive or that are delegated to such officer by the Board of Directors. The President shall … may from time to time prescribe. In addition, the Secretary shall perform such duties and have such powers as are incident to the office
S-1
EX-3.4
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
that are commonly incident to the office of the chief executive or that are delegated to such officer by the Board of Directors. The President shall … may from time to time prescribe. In addition, the Secretary shall perform such duties and have such powers as are incident to the office
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
are consummated or this Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its … obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares
8-K
EX-1.1
VERV
Verve Therapeutics Inc
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
and expenses incident to the performance of its obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance … , sale, preparation and delivery of the Shares and any taxes payable in that connection; (ii) the costs incident to the preparation, printing and filing
S-1/A
EX-1.1
VERV
Verve Therapeutics Inc
14 Jun 21
IPO registration (amended)
6:15am
is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including … without limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes payable
DRS
EX-3.2
4kws tfj02t17t7u5
16 Apr 21
Draft registration statement
12:00am
S-1
EX-3.2
np9l4oot
28 May 21
IPO registration
4:04pm
S-3
EX-1.2
rxcgxmaj54q awnf
1 Jul 22
Shelf registration
4:36pm
DRS
EX-10.13
j8gosdbfr960jb03
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.12
kavckpdfqt q0iio2s
28 May 21
IPO registration
4:04pm
10-Q
k7j1qcg6kh2w2brcx ah
12 Aug 21
Quarterly report
8:53am